These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2933507)

  • 1. The susceptibility of experimental glomerulonephritis in six different strains of mice.
    Nagai H; Yamada H; Nishigaki T; Nakazawa M; Koda A
    J Pharmacobiodyn; 1985 Jul; 8(7):586-9. PubMed ID: 2933507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental glomerulonephritis in mice as a model for immunopharmacological studies.
    Nagai H; Takizawa T; Nishiyori T; Koda A
    Jpn J Pharmacol; 1982 Dec; 32(6):1117-24. PubMed ID: 6891726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological studies on nephrotoxic serum nephritis accelerated with rabbit gamma-globulin in mice.
    Nose T; Tsurumi K; Kawada K; Nagai H; Yamada H; Yakuo I; Ojima A; Koda A
    Inflammation; 1989 Aug; 13(4):401-14. PubMed ID: 2474495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacological studies on experimental glomerulonephritis.
    Nagai H; Koda A; Mori H; Shimazawa T
    Int J Immunopharmacol; 1983; 5(3):235-44. PubMed ID: 6618743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
    Izumino K; Iida H; Asaka M; Mizumura Y; Sasayama S
    Nephron; 1986; 43(1):56-61. PubMed ID: 2939358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological studies on experimental nephritic rats (11). Changes in pathohistological and biochemical parameters in anti-rat GBM rabbit serum-induced nephritis (author's transl)].
    Suzuki Y; Nagamatsu T; Kito T; Kohmura T; Ito M
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):407-17. PubMed ID: 7286845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-drug treatment of autologous immune complex glomerulonephritis.
    Fleuren GJ; Hoedemaeker PJ
    Clin Exp Immunol; 1980 Aug; 41(2):218-24. PubMed ID: 6449335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 6-amidino-2-naphtyl-4-guanidinobenzoate dimethane sulfonate (FUT-175) on experimental glomerulonephritis in mice.
    Nagai H; Yamada H; Matsuura N; Inagaki N; Shimazawa T; Koda A
    Jpn J Pharmacol; 1984 May; 35(1):55-60. PubMed ID: 6471619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain distribution pattern of susceptibility to immune-mediated nephritis.
    Xie C; Sharma R; Wang H; Zhou XJ; Mohan C
    J Immunol; 2004 Apr; 172(8):5047-55. PubMed ID: 15067087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression.
    Xie C; Qin X; Jonnala G; Gong Y; Yan M; Zong P; Zhou XJ; Mohan C
    Clin Immunol; 2007 Jul; 124(1):49-56. PubMed ID: 17500042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of guifu dihuang pills extract on rabbit IgG accelerated mouse nephritis induced by nephrotoxic serum].
    Xiong YL; Wang JH; Zong GZ; Tu GR; Feng QR; He W; Cai HB; Yu JG; Hui LQ
    Zhongguo Zhong Yao Za Zhi; 1994 May; 19(5):302-4, inside backcover. PubMed ID: 7945874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice.
    Bird JE; Giancarli MR; Kurihara T; Kowala MC; Valentine MT; Gitlitz PH; Pandya DG; French MH; Durham SK
    Kidney Int; 2000 Jan; 57(1):129-36. PubMed ID: 10620194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and multiple drug therapy in autologous immune complex nephritis in rats.
    Kupor LR; Lowance DC; McPhaul JJ
    J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
    Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
    J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant.
    STEBLAY RW
    J Exp Med; 1962 Aug; 116(2):253-72. PubMed ID: 13916466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of human and mouse pepsins on Masugi nephritis].
    Ohnishi H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):105-14. PubMed ID: 6430759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pepsin on autologous immune complex glomerulonephritis.
    Ohnishi H
    Life Sci; 1983 Aug; 33(7):671-7. PubMed ID: 6224064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). II. Effect of CCAq on experimental glomerulonephritis.
    Nagai H; Shimazawa T; Takizawa T; Koda A; Yagi A; Nishioka I
    Jpn J Pharmacol; 1982 Oct; 32(5):823-31. PubMed ID: 7176217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
    Xie C; Zhou XJ; Liu X; Mohan C
    Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.